NCT02752477

Brief Summary

The objective of this trial is to determine whether an opioid-free general anesthetic (OFA) technique utilizing ketamine, dexmedetomidine, and lidocaine infusions can help reduce postoperative pain in opiate-dependent chronic pain patients (CPPs) undergoing spine surgery when compared with traditional opioid-containing techniques. It is expected that this OFA regimen will have a measurable reduction on postoperative opioid consumption and pain scores in CPPs.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for phase_3 chronic-pain

Timeline
Completed

Started Aug 2016

Longer than P75 for phase_3 chronic-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2016

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 27, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

August 2, 2016

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

March 26, 2020

Status Verified

March 1, 2020

Enrollment Period

4.1 years

First QC Date

March 29, 2016

Last Update Submit

March 24, 2020

Conditions

Keywords

Opioid-sparing

Outcome Measures

Primary Outcomes (1)

  • Quantified opioid-consumption

    48 hours following surgery

Secondary Outcomes (3)

  • Visual analogue scale (VAS) pain scores

    48 hours following surgery

  • Time of stay in post-anesthetic care unit (PACU)

    up to 5 hours following surgery

  • Incidence of adverse events

    48 hours following surgery

Study Arms (2)

Opioid-free anesthetic (OFA) group

EXPERIMENTAL
Drug: Opioid-free general anesthetic

Traditional Anesthesia (TA) group

ACTIVE COMPARATOR
Drug: Traditional general anesthetic

Interventions

An opioid-free general anesthetic technique utilizing dexmedetomidine, ketamine, and lidocaine infusions

Opioid-free anesthetic (OFA) group

Traditional general anesthetic technique utilizing sufentanil, fentanyl or remifentanil

Traditional Anesthesia (TA) group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic pain \> 6 months, opiate-using patients scheduled for thoracic or lumbar spinal surgery

You may not qualify if:

  • Pregnant or breastfeeding women, significant hepatic, renal or cardiac disease, allergy to any of the study drugs, inability to consent, respond to pain assessments or use the patient controlled analgesia device

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal University Hospital

Saskatoon, Saskatchewan, S7N 0W8, Canada

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ben Lim, MD

    University of Saskatchewan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

March 29, 2016

First Posted

April 27, 2016

Study Start

August 2, 2016

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

March 26, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations